Suppr超能文献

儿科研究中的可接受风险:美国公众的观点。

Acceptable Risks in Pediatric Research: Views of the US Public.

机构信息

Departments of Bioethics.

Biostatistics and Clinical Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland.

出版信息

Pediatrics. 2022 Jan 1;149(1). doi: 10.1542/peds.2021-052687.

Abstract

BACKGROUND AND OBJECTIVES

Critics argue that it is unethical to expose children to research risks for the benefit of others, whereas many regulations permit "net-risk" pediatric research but only when the risks are minimal. In the present survey, we assessed whether the US public agrees with these views and whether the US public's views regarding the acceptability of net-risk pediatric research are influenced by its social value.

METHODS

A 15-minute survey of a nationally representative sample of US adults. Participants were randomly assigned to 1 of 4 hypothetical scenarios involving procedures that pose increasing levels of risk. To assess whether respondents' views on the acceptability of the risks is influenced by the social value of the research, in each of the 4 scenarios we described the respective procedure being used in 3 studies with increasing levels of social value.

RESULTS

A total 1658 of the 2508 individuals who were sent the survey link participated (response rate = 66.1%). Approximately 91% approved of a research blood draw in minors, and ∼69% approved of a research bone marrow biopsy. The proportion who indicated that the respective procedure was acceptable increased as the study's social value increased. This effect was significantly stronger for studies which pose greater risks compared with studies with lower risks (P < .001).

CONCLUSIONS

The vast majority of the US public supports net-risk pediatric research that poses minimal risk, and a majority supports net-risk pediatric research that poses somewhat greater risks, provided it has high social value. These findings offer important information for assessing when it is acceptable to conduct net-risk pediatric research.

摘要

背景和目的

批评者认为,让儿童为了他人的利益而承受研究风险是不道德的,而许多法规允许进行“净风险”儿科研究,但前提是风险极小。在本研究中,我们评估了美国公众是否同意这些观点,以及美国公众对净风险儿科研究可接受性的看法是否受到其社会价值的影响。

方法

对美国成年人进行了一项全国代表性样本的 15 分钟调查。参与者被随机分配到 4 个假设情景中的 1 个,这些情景涉及风险逐渐增加的程序。为了评估受访者对风险可接受性的看法是否受到研究社会价值的影响,在 4 个情景中的每一个中,我们描述了各自的程序正在用于社会价值逐渐增加的 3 项研究中。

结果

在收到调查链接的 2508 人中,共有 1658 人参与了调查(回应率=66.1%)。大约 91%的人赞成在未成年人中进行研究性采血,约 69%的人赞成进行研究性骨髓活检。随着研究的社会价值增加,表明该程序可以接受的比例增加。与风险较低的研究相比,这种效果在风险较高的研究中更为明显(P<.001)。

结论

绝大多数美国公众支持风险极小的净风险儿科研究,大多数人支持风险略高的净风险儿科研究,前提是其具有较高的社会价值。这些发现为评估何时进行净风险儿科研究是可接受的提供了重要信息。

相似文献

1
Acceptable Risks in Pediatric Research: Views of the US Public.
Pediatrics. 2022 Jan 1;149(1). doi: 10.1542/peds.2021-052687.
2
Do the Potential Medical Benefits of Phase 1 Pediatric Oncology Trials Justify the Risks? Views of the United States Public.
J Pediatr. 2021 Nov;238:249-258.e3. doi: 10.1016/j.jpeds.2021.06.009. Epub 2021 Jun 16.
3
Views of adolescents and parents on pediatric research without the potential for clinical benefit.
Pediatrics. 2012 Oct;130(4):692-9. doi: 10.1542/peds.2012-0068. Epub 2012 Sep 10.
5
Consumer Views on Using Digital Data for COVID-19 Control in the United States.
JAMA Netw Open. 2021 May 3;4(5):e2110918. doi: 10.1001/jamanetworkopen.2021.10918.
8
Health research participants' preferences for receiving research results.
Clin Trials. 2016 Dec;13(6):582-591. doi: 10.1177/1740774516665598. Epub 2016 Aug 24.
9
Children's and their parents' views on facing research risks for the benefit of others.
Arch Pediatr Adolesc Med. 2008 Jan;162(1):9-14. doi: 10.1001/archpediatrics.2007.3.
10
Pragmatic Randomized Trials Without Standard Informed Consent?: A National Survey.
Ann Intern Med. 2015 Sep 1;163(5):356-64. doi: 10.7326/M15-0817.

引用本文的文献

1
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians.
Paediatr Drugs. 2024 Jul;26(4):365-379. doi: 10.1007/s40272-024-00633-x. Epub 2024 May 16.

本文引用的文献

1
Do the Potential Medical Benefits of Phase 1 Pediatric Oncology Trials Justify the Risks? Views of the United States Public.
J Pediatr. 2021 Nov;238:249-258.e3. doi: 10.1016/j.jpeds.2021.06.009. Epub 2021 Jun 16.
2
Bleeding Complications after Pediatric Kidney Biopsy: A Systematic Review and Meta-Analysis.
Clin J Am Soc Nephrol. 2019 Jan 7;14(1):57-65. doi: 10.2215/CJN.05890518. Epub 2018 Dec 6.
3
Encouraging Trends in Modern Phase 1 Oncology Trials.
N Engl J Med. 2018 Jun 7;378(23):2242-2243. doi: 10.1056/NEJMc1803837.
4
Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis.
PLoS Med. 2018 Feb 20;15(2):e1002505. doi: 10.1371/journal.pmed.1002505. eCollection 2018 Feb.
7
Parental and staff perspectives of NICU research procedures.
BMC Pediatr. 2016 May 10;16:63. doi: 10.1186/s12887-016-0600-3.
8
The Native Kidney Biopsy: Update and Evidence for Best Practice.
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):354-62. doi: 10.2215/CJN.05750515. Epub 2015 Sep 2.
9
How should we regulate risk in biomedical research? An ethical analysis of recent policy proposals and initiatives.
Health Policy. 2014 Sep;117(3):409-20. doi: 10.1016/j.healthpol.2014.04.011. Epub 2014 May 14.
10
Higher-hazard, no benefit research involving children: parental perspectives.
Pediatrics. 2013 Nov;132(5):e1302-9. doi: 10.1542/peds.2013-1700. Epub 2013 Oct 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验